Acuitas Investments, LLC

SEATTLE, WA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 6, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$2.6M2026 Q3
Positions13
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.98.6%

Acuitas Investments, LLC reported 13 positions worth $2.6M as of September 30, 2026 (13F filed November 6, 2026). Largest holding: BMRN (16.5%).

10 / 13 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 BMRNBiomarin Pharmaceutical$420.0K16.46%7,000——-3.3%
▸ 2 SLBSLB$399.5K15.65%8,200——+2.8%
▸ 3 FSLRFirst Solar$385.4K15.10%2,200——-7.3%
▸ 4 GMEDGlobus Medical$299.6K11.74%4,000——-5.9%
▸ 5 UANCVR Partners$297.9K11.67%2,407——-16.3%
▸ 6 NFGCNew Found Gold$277.0K10.85%168,900———
▸ 7 BIDUBaidu$139.0K5.45%1,600——-14.9%
▸ 8 MCHXMarchex$132.5K5.19%102,734———
▸ 9 TET1 Energy$125.5K4.92%32,500——-61.4%
▸ 10 BBDBank Bradesco$40.1K1.57%11,400——-30.7%

Pro Feature

The remaining 3 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Acuitas Investments, LLC hold as of Q3 2026?

Acuitas Investments, LLC reported 13 positions worth $2.6M in its Q3 2026 13F filing. Largest positions: BMRN (16.5%), SLB (15.7%), FSLR (15.1%), GMED (11.7%) and UAN (11.7%).

What did Acuitas Investments, LLC buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Acuitas Investments, LLC sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.